Platelet-rich plasma is one of the few medical treatments where you will be quoted a price up front, told it isn't covered, and asked to decide on the spot. That puts you in the position of a shopper rather than a patient — without a fee schedule, an insurer, or any published benchmark to tell you whether the number is reasonable.

This guide is about the number. It's information, not medical advice, and it can't tell you whether PRP is right for your condition.

A note on why our directory listings say "Not listed" for price: most providers don't publish one, and we won't invent or estimate a figure for a specific practice. The ranges below are the ranges patients encounter across the US market. They are approximate, they are not a survey, and no figure here belongs to any particular clinic.

The ranges you'll actually see

Per-session, cash-pay, in the United States, roughly:

  • Scalp PRP for hair loss: about $500–$1,500 a session, usually sold as three or four sessions, so $1,500–$4,500 for an initial course, plus maintenance later.
  • A single joint (knee, hip, shoulder): about $500–$1,500 per injection. Two joints in one visit usually costs less than double, but not half again.
  • Tendon and soft tissue (tennis elbow, plantar fascia, rotator cuff): about $500–$1,200.
  • Facial PRP with microneedling: about $400–$1,200 a session, again typically sold in threes.
  • Intradiscal, spine, or multi-level injections: commonly $1,500–$4,000 and up, because of imaging, guidance, and facility time.
  • Bone marrow aspirate concentrate or adipose-derived "stem cell" procedures, which are often marketed alongside PRP: $2,500–$10,000+. These are a different regulatory category and carry more FDA scrutiny.

An initial consultation may run $100–$400 and is sometimes credited toward treatment. Ultrasound guidance is bundled at some offices and billed separately, often $100–$300, at others.

Geography moves these numbers more than almost anything else. The same protocol in a high-cost metro can run two to three times what it costs a few hours away.

Why there is no standard price

PRP is not one product. "PRP" describes any preparation made by spinning your own blood to concentrate platelets, and the finished product varies enormously between systems — in platelet concentration, final volume, white cell content, and whether red cells are included. Reviewers of the literature have complained for years that trials rarely report these variables, which makes studies hard to compare with each other, let alone with what's in the syringe at any given office.

That variability flows straight into price:

Kit and equipment cost. Single-use commercial separation kits range from tens of dollars to several hundred. A practice using a high-yield double-spin system with an expensive disposable has a real cost floor that a practice using a basic tube does not.

Dose and volume. Drawing 60 mL of blood to make a larger, more concentrated injection costs more in supplies and chair time than drawing 15 mL.

Guidance. An intra-articular knee injection placed under ultrasound involves equipment, training, and time. Blind injections are cheaper and, in some anatomic locations, less reliable.

Who is doing it and where. A procedure performed by a physician in a suite with sterile setup and a medical assistant costs more to deliver than one performed in a treatment room by an aesthetician-supported workflow. That's not a judgment about outcomes — it's just overhead.

Add-ons. Microneedling, hyaluronic acid, alpha-2-macroglobulin, "exosomes," nutraceutical protocols, and post-procedure devices all get stacked onto quotes. Be especially careful with exosome products: the FDA has issued a public safety notification about unapproved exosome products after reports of serious adverse events, and there are no approved exosome therapies for these uses.

Sedation or facility fees, if the procedure is done in a surgical setting.

Marketing. In a cash-pay market, the cost of acquiring a patient is part of the price of the treatment. Practices that advertise heavily are recovering that spend somewhere.

Why insurance almost never pays

Most insurers classify PRP for musculoskeletal, hair, aesthetic, and sexual-health indications as investigational or not medically necessary. The billing code most often used for PRP injection is a temporary CPT code in the range reserved for emerging technologies — a signal, in itself, that payers have not accepted it as standard care.

Medicare's long-standing position has been non-coverage for autologous PRP with a narrow exception: it may be covered for certain chronic non-healing wounds, including diabetic foot wounds, under specific conditions and with data collection requirements. That exception does not extend to knees, elbows, scalps, or faces.

The deeper reason is regulatory. The overwhelming majority of PRP uses are not FDA-approved. What that actually means matters:

  • Many of the devices that spin and separate blood are FDA-cleared through the 510(k) pathway, and you can look up a specific system in the FDA's 510(k) database. Clearance of a centrifuge kit is not approval of a treatment for your condition. A clinic saying "we use an FDA-cleared system" is making a true but much narrower claim than it sounds.
  • Because PRP is made from your own blood and returned to you in the same visit, it generally sits outside the drug-approval process and is treated as the practice of medicine. The FDA has published consumer guidance on regenerative medicine therapies urging patients to ask whether a product is FDA-approved or being studied under an investigational application, and has separately warned consumers about unproven stem cell offerings.
  • "Not FDA-approved" does not mean "illegal" or "useless." It means no regulator has reviewed evidence and concluded the treatment works for your indication. It also means nobody is checking the marketing claims.

The evidence picture is genuinely mixed, which is the honest reason payers hold out. A Cochrane review of platelet-rich therapies for musculoskeletal soft tissue injuries found insufficient evidence to support routine use, with small effects and low-quality trials. Later high-quality randomized trials in knee osteoarthritis — including a widely cited 2021 trial in JAMA comparing intra-articular PRP with saline placebo over 12 months — found no meaningful benefit over placebo on pain or cartilage volume, while other trials and meta-analyses have reported modest symptom improvement. You are paying full price into an unsettled question.

What a "package" actually includes

Packages are how most PRP is sold, and they are where quotes get slippery. Before you pay, get the following in writing:

  • How many sessions, over what time window, and whether unused sessions expire.
  • Whether the consult, follow-up visits, and imaging are included, or billed separately.
  • What happens if you need more. If the protocol is three sessions and you're a partial responder, is the fourth at package rate or full price?
  • Maintenance cost. For hair and aesthetic indications especially, benefit that fades means an indefinite annual expense. Ask what year two costs.
  • Whether anything will be billed to your insurance. Some offices bill the office visit or ultrasound even when the injection is cash-pay. You want to know before an explanation of benefits surprises you.
  • Refund or non-response policy. Most have none. That's normal, but you should hear it out loud.

Ask one technical question too: what platelet concentration or total platelet dose does their system deliver, and can they show you the manufacturer's spec? Many offices can't answer. It's a fair proxy for how much the protocol is driven by evidence versus by what a distributor sold them.

Price is not a proxy for quality

There is no relationship in this market between what you pay and the dose you receive. A higher price may buy better guidance, a better-yielding system, and more physician time — or it may buy a nicer waiting room and a larger ad budget. A lower price may reflect an efficient practice, or a cheaper kit and a blind injection.

So don't shop on price alone in either direction. Shop on: who performs the injection, whether guidance is used for deep targets, whether the office can describe its preparation protocol, and whether they'll tell you plainly what the evidence for your indication looks like — including its weaknesses.

Paying for it

HSA and FSA funds can sometimes be used for PRP when it treats a medical condition; purely cosmetic procedures are excluded from the definition of deductible medical care. IRS Publication 502 sets out the rules, and a plan administrator may ask for a letter of medical necessity. Don't rely on a clinic's assurance here.

Medical credit cards and third-party financing are common, and the deferred-interest structures can be punitive if you don't clear the balance in the promotional window. A treatment with uncertain benefit is a poor candidate for debt.

Finally, consider the alternative use of the money. For many of the conditions PRP is marketed for, there are lower-cost interventions with stronger evidence behind them — supervised exercise therapy for knee osteoarthritis, or approved topical and oral drugs for androgenetic alopecia. If you're spending $2,000 either way, it's worth knowing which option the literature actually supports before you spend it.